glp-1 agonists and sglt2 inhibitors vs for CKD: Which Is Better? Prescribe SGLT2 inhibitors, GLP-1 receptor

Nanomedicine 14, 7793

GLP-1 agonists are typically recommended by NICE for patients with type 2 diabetes who have not achieved adequate glycaemic control on oral agents and meet specific criteria

Key studies in ME/CFS include Germain et al

These include peptic ulcer disease, non-gallstone-related acute cholecystitis, and non-gallstone-related pancreatitis (Shaffer 2018)

however, the aging brain exhibits heightened basal levels of proinflammatory cytokines such as interleukin-6 (IL-6), as well as a disequilibrium of anti-inflammatory signals, resulting in activation of CNS-resident microglia (Pachter et al., 2003

oral medication